Literature DB >> 9481396

Total gastrectomy is not necessary for proximal gastric cancer.

L E Harrison1, M S Karpeh, M F Brennan.   

Abstract

BACKGROUND: Although there is an increasing incidence of proximal gastric cancers in the United States, the appropriate extent of resection for proximal gastric cancer is not known. This study addresses whether the type of operation (total gastrectomy [TG] vs proximal gastrectomy [PG]) affects outcome for proximal gastric adenocarcinoma.
METHODS: Review of the prospective gastric database at Memorial Sloan-Kettering Cancer Center from July 1985 to August 1995 identified 391 patients with proximal gastric cancer. Of those patients, 98 underwent curative TG or PG through an exclusively abdominal approach. Patients undergoing esophagogastrectomy (n = 293) were excluded from analysis. Data are expressed as medians and ranges.
RESULTS: The length of hospital stay was the same for patients undergoing resection for PG (16.5 days [range 8 to 55]) and for TG (18 days [range 8 to 48]). In addition, hospital mortality rates for PG (6.0%) were similar to those for TG (3.0%). There was no significant difference in tumor differentiation and overall stage between the groups that underwent TG and those that underwent PG. There was no significant difference in time to recurrence between the two operative groups (PG, 15.7 months, versus TG, 18 months). In addition, there was no association between first site of recurrence and type of procedure. The overall 5-year survival rate for proximal gastric cancer was 43% (median survival 46 months), whereas the 5-year survival rate for TG was 41% (median survival 51 months; difference not significant).
CONCLUSIONS: The extent of resection for proximal gastric cancer does not affect long-term outcome. TG and PG have similar overall survival rates and time and rate of recurrence, and both procedures can be accomplished safely.

Entities:  

Mesh:

Year:  1998        PMID: 9481396

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  64 in total

1.  Gastric Cancer.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

2.  Long-term results of proximal and total gastrectomy for adenocarcinoma of the upper third of the stomach.

Authors:  Chang Hak Yoo; Byung Ho Sohn; Won Kon Han; Won Kil Pae
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

3.  Issues in the management of the upper third gastric cancer.

Authors:  Han-Kwang Yang
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

4.  Gastric tube reconstruction reduces postoperative gastroesophageal reflux in adenocarcinoma of esophagogastric junction.

Authors:  Xiu-Feng Chen; Bo Zhang; Zhi-Xin Chen; Jian-Kun Hu; Bin Dai; Fang Wang; Hong-Xin Yang; Jia-Ping Chen
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

5.  Laparoscopic lymphadenectomy around the left renal vein (16a2lat) by tunneling under the pancreas for advanced Siewert type II adenocarcinoma.

Authors:  Shuji Takiguchi; Yasuhiro Miyazaki; Kohei Murakami; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2015-10-19       Impact factor: 2.549

Review 6.  Quality of life: A critical outcome for all surgical treatments of gastric cancer.

Authors:  Michael D McCall; Peter J Graham; Oliver F Bathe
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study.

Authors:  Chang Hak Yoo; Byung Ho Sohn; Won Kon Han; Won Kil Pae
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

Review 8.  Current role of surgical therapy in gastric cancer.

Authors:  Ryan Swan; Thomas J Miner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

9.  Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa; Haruhiko Cho; Akira Tsuburaya; Osamu Kobayashi
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

10.  Long-term outcome after proximal gastrectomy with jejunal interposition for gastric cancer compared with total gastrectomy.

Authors:  Isao Nozaki; Shinji Hato; Takaya Kobatake; Koji Ohta; Yoshirou Kubo; Akira Kurita
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.